|
|
| Line 1: |
Line 1: |
| - | <!-- *** What falls between these lines is the Alert Box! You can remove it from your pages once you have read and understood the alert *** -->
| + | {{:Team:EPF-Lausanne/Templates/Header|title=Welcome}} |
| | | | |
| - | <html>
| + | ==Safety== |
| - | <div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
| + | |
| - | <div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
| + | |
| - | This is a template page. READ THESE INSTRUCTIONS.
| + | |
| - | </div>
| + | |
| - | <div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
| + | |
| - | You are provided with this team page template with which to start the iGEM season. You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki. You can find some examples <a href="https://2008.igem.org/Help:Template/Examples">HERE</a>.
| + | |
| - | </div>
| + | |
| - | <div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
| + | |
| - | You <strong>MUST</strong> have a team description page, a project abstract, a complete project description, a lab notebook, and a safety page. PLEASE keep all of your pages within your teams namespace.
| + | |
| - | </div>
| + | |
| - | </div>
| + | |
| - | </html>
| + | |
| | | | |
| - | <!-- *** End of the alert box *** -->
| + | The 2011 EPFL iGEM team has taken two approaches to its engineering work on transcription factors: one is in vivo and the other is in vitro. Neither presents any form of unusual safety risk. Nevertheless, we should highlight a few aspects of the work that present some risk to the public and to the researcher. |
| | | | |
| | + | § The ''in vivo'' manipulation of ''E. coli'' using various antibiotics, like ampicillin and kanamycin, always presents a minimal amount of risk to those who would be exposed to a resistant strain. |
| | | | |
| | | | |
| - | {|align="justify"
| |
| - | |You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing.
| |
| - | |[[Image:EPF-Lausanne_logo.png|200px|right|frame]]
| |
| - | |-
| |
| - | |
| |
| - | ''Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs)''
| |
| - | |[[Image:EPF-Lausanne_team.png|right|frame|Your team picture]]
| |
| - | |-
| |
| - | |
| |
| - | |align="center"|[[Team:EPF-Lausanne | Team Example]]
| |
| - | |}
| |
| - |
| |
| - | <!--- The Mission, Experiments --->
| |
| - |
| |
| - | {| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
| |
| - | !align="center"|[[Team:EPF-Lausanne|Home]]
| |
| - | !align="center"|[[Team:EPF-Lausanne/Team|Team]]
| |
| - | !align="center"|[https://igem.org/Team.cgi?year=2010&team_name=EPF-Lausanne Official Team Profile]
| |
| - | !align="center"|[[Team:EPF-Lausanne/Project|Project]]
| |
| - | !align="center"|[[Team:EPF-Lausanne/Parts|Parts Submitted to the Registry]]
| |
| - | !align="center"|[[Team:EPF-Lausanne/Modeling|Modeling]]
| |
| - | !align="center"|[[Team:EPF-Lausanne/Notebook|Notebook]]
| |
| - | !align="center"|[[Team:EPF-Lausanne/Safety|Safety]]
| |
| - | !align="center"|[[Team:EPF-Lausanne/Attributions|Attributions]]
| |
| - | |}
| |
| - |
| |
| - |
| |
| - | ==Safety==
| |
| | | | |
| - | Please use this page to answer the safety questions posed on the [[Safety | safety page]].
| + | {{:Team:EPF-Lausanne/Templates/Footer}} |
Welcome
Safety
The 2011 EPFL iGEM team has taken two approaches to its engineering work on transcription factors: one is in vivo and the other is in vitro. Neither presents any form of unusual safety risk. Nevertheless, we should highlight a few aspects of the work that present some risk to the public and to the researcher.
§ The in vivo manipulation of E. coli using various antibiotics, like ampicillin and kanamycin, always presents a minimal amount of risk to those who would be exposed to a resistant strain.
"
